News for AMAG Stock

Landsdowne Labs Names Bryan Laulicht CEO Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection) Covis Group Completes Acquisition of AMAG Pharmaceuticals Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection) Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment Conference AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate Update AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand AMAG Pharmaceuticals Announces Leadership Changes AMAG Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on Monday, May 11, 2020